updates – Ophthalmological Society of Ghana https://osg-ghana.org Universal eye health for all Ghanaians Sat, 17 Aug 2024 03:42:31 +0000 en-US hourly 1 https://wordpress.org/?v=6.6.2 2023 AGM and Scientific Conference https://osg-ghana.org/2023-agm-and-scientific-conference/ Mon, 07 Aug 2023 13:30:24 +0000 https://osg-ghana.org/?p=3934 more

]]> 2022 AGM and Scientific Conference https://osg-ghana.org/2022-agm-and-scientific-conference/ Mon, 25 Jul 2022 03:45:30 +0000 https://osg-ghana.org/?p=3800 more

]]> Cardiovascular disease implicated in rapid glaucoma progression https://osg-ghana.org/cardiovascular-disease-implicated-in-rapid-glaucoma-progression/ https://osg-ghana.org/cardiovascular-disease-implicated-in-rapid-glaucoma-progression/#respond Tue, 07 Nov 2017 09:27:31 +0000 https://osg-ghana.org/?p=239 more

]]> https://osg-ghana.org/cardiovascular-disease-implicated-in-rapid-glaucoma-progression/feed/ 0 Meta-analysis finds comparable safety profiles between bevacizumab and ranibizumab https://osg-ghana.org/meta-analysis-finds-comparable-safety-profiles-between-bevacizumab-and-ranibizumab/ https://osg-ghana.org/meta-analysis-finds-comparable-safety-profiles-between-bevacizumab-and-ranibizumab/#respond Tue, 07 Nov 2017 09:25:51 +0000 https://osg-ghana.org/?p=237 more

]]> https://osg-ghana.org/meta-analysis-finds-comparable-safety-profiles-between-bevacizumab-and-ranibizumab/feed/ 0 Low-cost ziv-aflibercept appears safe for intraocular administration https://osg-ghana.org/low-cost-ziv-aflibercept-appears-safe-for-intraocular-administration/ https://osg-ghana.org/low-cost-ziv-aflibercept-appears-safe-for-intraocular-administration/#respond Tue, 07 Nov 2017 09:11:17 +0000 https://osg-ghana.org/?p=231 more

]]> https://osg-ghana.org/low-cost-ziv-aflibercept-appears-safe-for-intraocular-administration/feed/ 0 Telemedicine screening confirms acute ROP is typically symmetrical https://osg-ghana.org/telemedicine-screening-confirms-acute-rop-is-typically-symmetrical/ https://osg-ghana.org/telemedicine-screening-confirms-acute-rop-is-typically-symmetrical/#respond Tue, 07 Nov 2017 09:08:46 +0000 https://osg-ghana.org/?p=229 more

]]> https://osg-ghana.org/telemedicine-screening-confirms-acute-rop-is-typically-symmetrical/feed/ 0 Timing of IOL repositioning surgery significantly impacts refractive outcomes https://osg-ghana.org/timing-of-iol-repositioning-surgery-significantly-impacts-refractive-outcomes/ https://osg-ghana.org/timing-of-iol-repositioning-surgery-significantly-impacts-refractive-outcomes/#respond Fri, 03 Nov 2017 18:36:20 +0000 https://osg-ghana.org/?p=108 more

]]> https://osg-ghana.org/timing-of-iol-repositioning-surgery-significantly-impacts-refractive-outcomes/feed/ 0 Injected mitomycin C offers advantages over standard application https://osg-ghana.org/injected-mitomycin-c-offers-advantages-over-standard-application/ https://osg-ghana.org/injected-mitomycin-c-offers-advantages-over-standard-application/#respond Fri, 03 Nov 2017 18:35:10 +0000 https://osg-ghana.org/?p=106 more

]]> https://osg-ghana.org/injected-mitomycin-c-offers-advantages-over-standard-application/feed/ 0 Panel issues first U.S. guidelines for childhood retinoblastoma screening https://osg-ghana.org/panel-issues-first-u-s-guidelines-for-childhood-retinoblastoma-screening/ https://osg-ghana.org/panel-issues-first-u-s-guidelines-for-childhood-retinoblastoma-screening/#respond Fri, 03 Nov 2017 18:14:07 +0000 https://osg-ghana.org/?p=100 more

]]> https://osg-ghana.org/panel-issues-first-u-s-guidelines-for-childhood-retinoblastoma-screening/feed/ 0